Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Maestro

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Oncotarget|June 17, 2014
GSK-3 as potential target for therapeutic intervention in cancerJames A McCubrey, Linda S Steelman, Fred E Bertrand, et al.
International Journal of Molecular Sciences|June 26, 2018
Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid ChondrosarcomaMilena Urbini, Valentina Indio, Annalisa Astolfi, et al.
Cancers|July 2, 2021
Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor CellsMichele Minopoli, Sabrina Sarno, Lucia Cannella, et al.
The American Journal of Surgical Pathology|May 14, 2015
KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based studySabrina Rossi, Daniela Gasparotto, Rosalba Miceli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 24, 2022
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic SamplesMiriam Redegalli, Greta Grassini, Gilda Magliacane, et al.
The Journal of Pathology|April 26, 2019
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomasMonica Brenca, Silvia Stacchiotti, Kelly Fassetta, et al.
Genes, Chromosomes & Cancer|April 7, 2017
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcomaMilena Urbini, Annalisa Astolfi, Maria Abbondanza Pantaleo, et al.
Ebiomedicine|May 29, 2017
A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal CancerAlessandra Viel, Alessandro Bruselles, Ettore Meccia, et al.
Frontiers in Oncology|May 16, 2022
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling SuppressionClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 20, 2025
miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancerMatteo Allegretti, David J Joun, Giulia Urbani, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Oncotarget|June 17, 2014
GSK-3 as potential target for therapeutic intervention in cancerJames A McCubrey, Linda S Steelman, Fred E Bertrand, et al.
International Journal of Molecular Sciences|June 26, 2018
Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid ChondrosarcomaMilena Urbini, Valentina Indio, Annalisa Astolfi, et al.
Cancers|July 2, 2021
Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor CellsMichele Minopoli, Sabrina Sarno, Lucia Cannella, et al.
The American Journal of Surgical Pathology|May 14, 2015
KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based studySabrina Rossi, Daniela Gasparotto, Rosalba Miceli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 24, 2022
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic SamplesMiriam Redegalli, Greta Grassini, Gilda Magliacane, et al.
The Journal of Pathology|April 26, 2019
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomasMonica Brenca, Silvia Stacchiotti, Kelly Fassetta, et al.
Genes, Chromosomes & Cancer|April 7, 2017
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcomaMilena Urbini, Annalisa Astolfi, Maria Abbondanza Pantaleo, et al.
Ebiomedicine|May 29, 2017
A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal CancerAlessandra Viel, Alessandro Bruselles, Ettore Meccia, et al.
Frontiers in Oncology|May 16, 2022
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling SuppressionClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 20, 2025
miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancerMatteo Allegretti, David J Joun, Giulia Urbani, et al.
Pageof 11